FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data
In response to the covid-19 pandemic, FDA has developed quality-controlled reference sequence data for the SARS-CoV-2 reference strain for the United States.
Read MorePosted by | Apr 8, 2020 | Biochemicals & Chemical Reagents, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
In response to the covid-19 pandemic, FDA has developed quality-controlled reference sequence data for the SARS-CoV-2 reference strain for the United States.
Read MorePosted by | Apr 7, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
SARS-CoV-2 PepTivator peptide pools work by stimulating T cells specific to the novel coronavirus, which allows subsequent detection, isolation, and further downstream research.
Read MorePosted by | Apr 7, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The Aries SARS-CoV-2 assay will run on the company’s Aries system, an FDA-cleared, automated molecular diagnostics platform for moderate-complexity labs.
Read MorePosted by | Apr 7, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
New IgM and IgG antibody assays from Beckman Coulter will help indicate whether a person potentially developed immunity against the covid-19 coronavirus, SARS-CoV-2.
Read MorePosted by | Apr 7, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Researchers used different reagents than those that are in short supply, and they were able to produce results in about a day using the ddPCR from Bio-Rad.
Read More